TearLab Corporation (TEAR) - Financial and Strategic SWOT Analysis Review

Date: June 1, 2016
Pages: 49
Price:
US$ 300.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: TE7A855879AEN
Leaflet:

Download PDF Leaflet

TearLab Corporation (TEAR) - Financial and Strategic SWOT Analysis Review
TearLab Corporation (TEAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

TearLab Corporation (TearLab) is an ophthalmic device company. It commercializes a proprietary in vitro diagnostic tear testing platform. The company’s flagship TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. Its osmolarity system is a CE marked and the US FDA cleared device. The company conducts it research and development activities through its wholly-owned subsidiary, TearLab Research, Inc. The company sells its products directly in the US, Canada and the UK and through distributors in Europe, South America and Asia. TearLab is headquartered in San Diego, California, the US.

TearLab Corporation Key Recent Developments

May 04, 2016: TearLab Reports Q1-16 Financial Results
Apr 20, 2016: TearLab Announces First Quarter 2016 Preliminary Financial Estimates
Mar 08, 2016: TearLab Reports Fourth Quarter and Full Year 2015 Financial Results
Feb 29, 2016: TearLab Announces Strategic Restructuring
Feb 01, 2016: TearLab Announces Fourth Quarter 2015 Preliminary Financial Estimates and Provides Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

TearLab Corporation - Key Facts
TearLab Corporation - Key Employees
TearLab Corporation - Key Employee Biographies
TearLab Corporation - Major Products and Services
TearLab Corporation - Medical Equipment Pipeline Products Data
TearLab Corporation Pipeline Products by Equipment Type
TearLab Corporation Pipeline Products by Development Stage
TearLab Corporation - History
TearLab Corporation - Company Statement
TearLab Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

TearLab Corporation - Business Description
TearLab Corporation - Corporate Strategy
TearLab Corporation - SWOT Analysis
SWOT Analysis - Overview
TearLab Corporation - Strengths
Strength - TearLab Osmolarity System
Strength - Growing Revenue upon CLIA Waiver
TearLab Corporation - Weaknesses
Weakness - Operating Loss Carryforward
Weakness - Declining Cash Reserves
TearLab Corporation - Opportunities
Opportunity - Restructuring Initiatives
Opportunity - Market Potential: Dry Eye Disease
Opportunity - Marketing Initiatives
Opportunity - Growing PoC Market
TearLab Corporation - Threats
Threat - Dependence on Third Party Suppliers
Threat - Stiff Competition
Threat - Stringent Regulations
TearLab Corporation - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

TearLab Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
TearLab Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
TearLab Corporation, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 04, 2016: TearLab Reports Q1-16 Financial Results
Apr 20, 2016: TearLab Announces First Quarter 2016 Preliminary Financial Estimates
Mar 08, 2016: TearLab Reports Fourth Quarter and Full Year 2015 Financial Results
Feb 29, 2016: TearLab Announces Strategic Restructuring
Feb 01, 2016: TearLab Announces Fourth Quarter 2015 Preliminary Financial Estimates and Provides Corporate Update
Nov 05, 2015: TearLab Reports Q3-15 Financial Results
Aug 06, 2015: TearLab Corporation Reports Q2-15 Financial Results
Jul 06, 2015: TearLab Announces Appointment of Wes Brazell as CFO
May 07, 2015: TearLab Reports Q1-15 Financial Results
Mar 12, 2015: TearLab Reports 2014 Financial Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

TearLab Corporation, Key Facts
TearLab Corporation, Key Employees
TearLab Corporation, Key Employee Biographies
TearLab Corporation, Major Products and Services
TearLab Corporation Number of Pipeline Products by Equipment Type
TearLab Corporation Pipeline Products by Equipment Type
TearLab Corporation Number of Pipeline Products by Development Stage
TearLab Corporation Pipeline Products by Development Stage
TearLab Corporation, History
TearLab Corporation, Subsidiaries
TearLab Corporation, Key Competitors
TearLab Corporation, Ratios based on current share price
TearLab Corporation, Annual Ratios
TearLab Corporation, Interim Ratios
TearLab Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
TearLab Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
TearLab Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

TearLab Corporation Pipeline Products by Equipment Type
TearLab Corporation Pipeline Products by Development Stage
TearLab Corporation, Performance Chart (2011 - 2015)
TearLab Corporation, Ratio Charts
TearLab Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
TearLab Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Advanced Tear Diagnostics, LLC
ReSearch Pharmaceutical Services, Inc.
LacriSciences, LLC
DiagnosTear Ltd.
TearScience, Inc.
Skip to top


Ask Your Question

TearLab Corporation (TEAR) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: